Acute Effects of Single-Dose Olanzapine on Metabolic, Endocrine, and Inflammatory Markers in Healthy Controls-Reference-Cited by-同舟云学术

Acute Effects of Single-Dose Olanzapine on Metabolic, Endocrine, and Inflammatory Markers in Healthy Controls

Published:2013-12 Issue:6 Volume:33 Page:740-746
ISSN:0271-0749
Container-title:Journal of Clinical Psychopharmacology
language:en
Short-container-title:

Author:

Hahn Margaret Karolina,Wolever Tom M.S.,Arenovich Tamara,Teo Celine,Giacca Adria,Powell Valerie,Clarke Leigh,Fletcher Paul,Cohn Tony,McIntyre Roger S.,Gomes Sylvia,Chintoh Araba,Remington Gary J.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Psychiatry and Mental health

Reference49 articles.

1. Evidence-based pharmacotherapy of schizophrenia.;Emsley;Int J Neuropsychopharmacol,2004

2. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review.;Newcomer;CNS Drugs,2005

3. Schizophrenia and increased risks of cardiovascular disease.;Hennekens;Am Heart J,2005

4. Diabetes mellitus and schizophrenia: historical perspective.;Kohen;Br J Psychiatry Suppl,2004

5. Phenomenology of and risk factors for new-onset diabetes mellitus and diabetic ketoacidosis associated with atypical antipsychotics: an analysis of 45 published cases.;Jin;Ann Clin Psychiatry,2002

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of Novel Tools for Dissection of Central Versus Peripheral Dopamine D2-Like Receptor Signaling in Dysglycemia;Diabetes;2024-06-13

2. Development of novel tools for dissection of central versus peripheral dopamine D₂-like receptor signaling in dysglycemia;2024-02-23

3. Amylin receptor agonism enhances the effects of liraglutide in protecting against the acute metabolic side effects of olanzapine;iScience;2024-01

4. Insulin Resistance/Diabetes and Schizophrenia: Potential Shared Genetic Factors and Implications for Better Management of Patients with Schizophrenia;CNS Drugs;2023-12-14

5. Activation of the PERK-CHOP signaling pathway during endoplasmic reticulum stress contributes to olanzapine-induced dyslipidemia;Acta Pharmacologica Sinica;2023-10-25